Skip to main content

India's first mRNA COVID vaccine gets DCGI nod for Phase 2/3 trials

Gennova Biopharmaceuticals Ltd., which is a Pune-based biotechnology company, had submitted the proposed Phase II/ Phase III study of India's first mRNA-based COVID vaccine, HGCO19. 



source https://www.jagranjosh.com/current-affairs/indias-first-mrna-covid-vaccine-gets-dcgi-nod-for-phase-23-trials-1629811338-1

Popular posts from this blog